Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study
This study is the first to characterize chronic myeloid leukaemia patients at a Portuguese centre. The patient characteristics, responses, and overall survival were within the expected range according to the literature. This study confirms the good prognosis of chronic myeloid leukaemia and the good responses using imatinib as first-line treatment.
Authors
- Rita Calisto (ORCID: https://orcid.org/0000-0002-5151-5245)
- José Mariz (ORCID: https://orcid.org/0000-0003-0240-4749)
- Susana Bizarro (ORCID: https://orcid.org/0000-0002-3495-2080)
- María José Bento (ORCID: https://orcid.org/0000-0002-7690-9830)
- Manuel R. Teixeira (ORCID: https://orcid.org/0000-0002-4896-5982)
- Ana Espírito Santo (ORCID: https://orcid.org/0000-0002-4840-590X)
- Pedro Martinho Gouveia (ORCID: https://orcid.org/0000-0001-7076-9075)
- Ana Maria Meireles (ORCID: https://orcid.org/0000-0002-6465-1174)
- Cláudia Moreira
Institutions
- Instituto Português de Oncologia Francisco Gentil (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- IPO Porto (PT)
Publication Details
- Journal
- Hematology Transfusion and Cell Therapy
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1016/j.htct.2025.103935
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Associação Portuguesa Contra a Leucemia